The value of randomized clinical trials in ophthalmology.
作者信息
Chew Emily Y
机构信息
Clinical Trials Branch, Division of Epidemiology and Clinical Applications, National Eye Institute/National Institutes of Health, Bethesda, Maryland 20892-1204, USA.
出版信息
Am J Ophthalmol. 2011 Apr;151(4):575-8. doi: 10.1016/j.ajo.2010.12.006.
Abstract
摘要
相似文献
1
The value of randomized clinical trials in ophthalmology.
Am J Ophthalmol. 2011 Apr;151(4):575-8. doi: 10.1016/j.ajo.2010.12.006.
2
Reporting the results of randomized clinical trials: a priority of Archives of Ophthalmology.
Arch Ophthalmol. 2004 Jul;122(7):1038-9. doi: 10.1001/archopht.122.7.1038.
3
Standards for Reporting Research Results: Implications for the Field of Health Education.
Health Educ Behav. 2016 Oct;43(5):497-500. doi: 10.1177/1090198116668519.
4
Eyes or subjects: are ophthalmic randomized controlled trials properly designed and analyzed?
Ophthalmology. 2012 Apr;119(4):869-72. doi: 10.1016/j.ophtha.2011.09.025. Epub 2012 Jan 9.
5
Improving the quality of reporting in randomised controlled trials.
J Wound Care. 2004 Mar;13(3):103-6. doi: 10.12968/jowc.2004.13.3.26593.
6
The quality of reporting of randomized clinical trials published in Ophthalmology.
Ophthalmology. 2001 Feb;108(2):410-5. doi: 10.1016/s0161-6420(00)00500-5.
7
The CONSORT statement: will it lead to improved reporting of clinical trials in ophthalmology? Consolidated Standards of Reporting Trials.
Arch Ophthalmol. 1999 May;117(5):677-80. doi: 10.1001/archopht.117.5.677.
8
Current Evidence From the Randomized Controlled Trials Rehabilitation Checklist (RCTRACK) Reporting Guideline Project.
Am J Phys Med Rehabil. 2021 Jan 1;100(1):2-4. doi: 10.1097/PHM.0000000000001617.
9
CONSORT 2010.
Lancet. 2010 Apr 3;375(9721):1136. doi: 10.1016/S0140-6736(10)60456-4. Epub 2010 Mar 24.
10
Enhancing CONSORT compliance for improved reporting of randomized controlled trials.
Am J Orthod Dentofacial Orthop. 2014 Jan;145(1):1. doi: 10.1016/j.ajodo.2013.11.005.
引用本文的文献
1
Willingness and Motivation of Saudi Patients with Keratoconus to Participate in Clinical Trials.
Cureus. 2021 Aug 30;13(8):e17580. doi: 10.7759/cureus.17580. eCollection 2021 Aug.
2
How Artificial Intelligence Can Transform Randomized Controlled Trials.
Transl Vis Sci Technol. 2020 Feb 12;9(2):9. doi: 10.1167/tvst.9.2.9.
本文引用的文献
1
Minimizing bias in randomized trials: the importance of blinding.
JAMA. 2010 Aug 18;304(7):793-4. doi: 10.1001/jama.2010.1161.
2
Some practical problems in implementing randomization.
Clin Trials. 2010 Jun;7(3):235-45. doi: 10.1177/1740774510368300.
3
Retraction--autologous myoblasts and fibroblasts versus collagen [corrected] for treatment of stress urinary incontinence in women: a [corrected] randomised controlled trial.
Lancet. 2008 Sep 6;372(9641):789-90. doi: 10.1016/S0140-6736(08)61320-3.
4
VISUAL PROGNOSIS OF PROLIFERATING DIABETIC RETINOPATHY.
Br J Ophthalmol. 1963 Oct;47(10):611-9. doi: 10.1136/bjo.47.10.611.
5
Role of the Data and Safety Monitoring Committee (DSMC).
Stat Med. 2002 Oct 15;21(19):2823-9. doi: 10.1002/sim.1286.
6
Women's health. The vanishing promises of hormone replacement.
Science. 2002 Jul 19;297(5580):325-6. doi: 10.1126/science.297.5580.325.
7
Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.
JAMA. 2002 Jul 17;288(3):321-33. doi: 10.1001/jama.288.3.321.
8
The Age-Related Eye Disease Study (AREDS): design implications. AREDS report no. 1.
Control Clin Trials. 1999 Dec;20(6):573-600. doi: 10.1016/s0197-2456(99)00031-8.
9
Data monitoring committees and interim monitoring guidelines.
Control Clin Trials. 1999 Oct;20(5):395-407. doi: 10.1016/s0197-2456(99)00017-3.
10
How effective are treatments for diabetic retinopathy?
JAMA. 1993 Mar 10;269(10):1290-1.
Zotero 插件